Preview

Current Pediatrics

Advanced search

ANTISPASMODIC MEDICATION WITH DIRECTIVE EFFECT IN CHILDREN WITH ABDOMINAL PAIN AT THE STAGE OF DIAGNOSTIC SEARCH

Abstract

Additional examination is needed for the purpose of detection of its etiology in some patients with abdominal pain, and it takes several days to prove a diagnosis. In most cases this pain is a result of muscle spasm in gastrointestinal tract. The administration of antispasmodic medication with directive effect, particularly, of hyoscine butylbromide (Buscopan), is well-grounded. Hyoscine butylbromide is M-cholinergic antagonist, it does not penetrates blood-brain barrier, does not induce common for cholinergic antagonists vascular reactions and decrease of blood pressure. This drug is used in pediatric practice for a long time, it can be used in patients 6 years old anв older, and it has good safety profile. 

Key words: abdominal pain, hyoscine butylbromide.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(1):168-170)

About the Author

Yu.A. Kozlova
M.F. Vladimirskiy Moscow Regional Scientific Clinical Institute
Russian Federation


References

1. Maitai C.K., Njoroge D.K., Munenge R.W. A comparative study of two antispasmodic products: Buscopan and NO Spa. East Afr. Med. J. 1985; 62 (7): 480–485.

2. Диагностика и лечение функциональных заболеваний органов пищеварения у детей. Рабочий протокол. М. 2005. С. 3–15.


Review

For citations:


Kozlova Yu. ANTISPASMODIC MEDICATION WITH DIRECTIVE EFFECT IN CHILDREN WITH ABDOMINAL PAIN AT THE STAGE OF DIAGNOSTIC SEARCH. Current Pediatrics. 2010;9(1):168-170.

Views: 770


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)